| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $35.2M | -4.5% |
| Cost of Revenue | $17.7M | -10.0% |
| Gross Profit | $17.5M | +1.7% |
| R&D Expense | $2.8M | +1.8% |
| SG&A Expense | $8.8M | -23.8% |
| Operating Income | $1.2M | +166.0% |
| Pre-tax Income | -$1.8M | +51.5% |
| Income Tax | $104K | +117.7% |
| Net Income | -$1.9M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $6.5M | +45.8% |
| Inventory | $473K | -18.7% |
| Current Assets | $11.4M | +11.7% |
| Total Assets | $40.3M | +7.0% |
| Current Liabilities | $8.6M | +33.2% |
| Long-term Debt | $42.7M | +0.2% |
| Total Liabilities | $51.8M | +5.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.3M | -12.1% |
| Investing Cash Flow | -$4.4M | -14.1% |
| Financing Cash Flow | -$64K | +82.5% |
| +38.9% |
| EPS (Basic) | -$0.16 | +38.5% |
| EPS (Diluted) | -$0.16 | +38.5% |
| Stockholders' Equity |
| -$11.5M |
| +0.6% |